Skip to content
★ Sign in to follow
RB

Rahul Batra

Beta Drugs Limited
Insider activity · 24 months1 buy0 sales
Total declarations
4
Company
1
▲ Purchases (1 ops.)
€19k
▼ Sales (0 ops.)
—

Latest filing published 29 Mar 2025 for Beta Drugs Limited.

Filing timeline

BuySale
Rahul Batra

Rahul Batra: trading record in brief

Rahul Batra discloses dealings in Beta Drugs Limited to SEBI (PIT + SAST). In total, 4 filings cover trades dated from 4 November 2021 to 27 March 2025.

Purchases make up the whole of the open-market record (1 purchase, €19k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Most recently, on 29 March 2025, the filings show a transaction in Beta Drugs Limited. The last purchase on record was published on 8 November 2021, which is 1,826 days ago. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Companies and markets linked to Rahul Batra

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    ExecutivesBeta Drugs Limited
    2SEBI
    1,982 sharesEquity SharesSEBI:5a1c1a2d761fe314225d6851c3cd5a7a01c1700e
    Canonical exit: 25 Jun 2025 (T+90)
  • ▲
    ExecutivesBeta Drugs Limited
    2M INR5SEBI
    2,400 shares@ ₹685.241732.9% of flowEquity SharesSEBI:a2598f60aaa9edc0f9787e0626d54eecba3e1cbf
    Canonical exit: 20 Apr 2023 (T+90)
  • ▲
    ExecutivesBeta Drugs Limited
    2M INR5SEBI
    2,400 shares@ ₹685.241732.9% of flowEquity SharesSEBI:1d4bfa14f33956c69b57dabb1808e7f6f21d1737
    Canonical exit: 20 Apr 2023 (T+90)
  • ▲
    ExecutivesBeta Drugs Limited
    2M INR5SEBI
    2,800 shares@ ₹598.121434.1% of flowEquity SharesSEBI:a9788a49c171a20b8ed3b903cb3915519225b9d8
    Canonical exit: 2 Feb 2022 (T+90)

4 of 4 declarations